UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting

Hematological oncology, 2020-12, Vol.38 (5), p.726-736

2020

Volltextzugriff (PDF)

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction

Postgraduate medical journal, 2021-12, Vol.97 (1154), p.762-763

2021

Volltextzugriff (PDF)

Epigenetic silencing of MIR203 in multiple myeloma

British journal of haematology, 2011-09, Vol.154 (5), p.569-578

2011

Volltextzugriff (PDF)

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma

Scientific reports, 2021-03, Vol.11 (1), p.7009-9, Article 7009

2021

Volltextzugriff (PDF)

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

Blood, 2004-07, Vol.104 (1), p.243-249

2004

Volltextzugriff (PDF)

Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop

Leukemia & lymphoma, 2018-10, Vol.59 (10), p.2305-2317

2018

Volltextzugriff (PDF)

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

Blood, 2004-06, Vol.103 (12), p.4630-4635

2004

Volltextzugriff (PDF)

Epigenetic Silencing of Tumor Suppressor lncRNA NKILA : Implication on NF-κB Signaling in Non-Hodgkin's Lymphoma

Genes, 2022-01, Vol.13 (1), p.128

2022

Volltextzugriff (PDF)

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network

Blood cancer journal (New York), 2019-10, Vol.9 (10), p.83-10, Article 83

2019

Volltextzugriff (PDF)

Epigenetic inactivation of the MIR129-2 in hematological malignancies

Journal of hematology and oncology, 2013-02, Vol.6 (1), p.16-16, Article 16

2013

Volltextzugriff (PDF)

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

Blood, 2012-10, Vol.120 (15), p.2973-2980

2012

Volltextzugriff (PDF)

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

Journal of clinical oncology, 2015-02, Vol.33 (6), p.657-664

2015

Volltextzugriff (PDF)

Molecular detection of minimal residual disease in multiple myeloma

British journal of haematology, 2018-04, Vol.181 (1), p.11-26

2018

Volltextzugriff (PDF)

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain

Therapeutic advances in hematology, 2022-03, Vol.13, p.20406207221082043-20406207221082043

2022

Volltextzugriff (PDF)

Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment

Clinical transplantation, 2012-09, Vol.26 (5), p.679-683

2012

Volltextzugriff (PDF)

miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration

Cell communication and signaling, 2021-05, Vol.19 (1), p.62-62, Article 62

2021

Volltextzugriff (PDF)

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

Frontiers in oncology, 2019-06, Vol.9, p.449-449

2019

Volltextzugriff (PDF)

Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced‐intensity conditioning second transplantation from the original donor

American journal of hematology, 2013-06, Vol.88 (6), p.485-491

2013

Volltextzugriff (PDF)

Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients

Annals of hematology, 2014-03, Vol.93 (3), p.493-498

2014

Volltextzugriff (PDF)

Epigenetic inactivation of the miR-124-1 in haematological malignancies

PloS one, 2011-04, Vol.6 (4), p.e19027

2011

Volltextzugriff (PDF)

DNA methylation of microRNA genes in multiple myeloma

Carcinogenesis (New York), 2012-09, Vol.33 (9), p.1629-1638

2012

Volltextzugriff (PDF)

Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma

Journal of clinical pathology, 2007-01, Vol.60 (1), p.104-106

2007

Volltextzugriff (PDF)

Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma

Journal of clinical pathology, 2007-06, Vol.60 (6), p.664-669

2007

Volltextzugriff (PDF)

Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR

Frontiers in oncology, 2021-01, Vol.10, p.611021-611021

2021

Volltextzugriff (PDF)

Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma

Journal of clinical pathology, 2015-07, Vol.68 (7), p.557-561

2015

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(134)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction

Epigenetic silencing of MIR203 in multiple myeloma

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

Epigenetic Silencing of Tumor Suppressor lncRNA NKILA : Implication on NF-κB Signaling in Non-Hodgkin's Lymphoma

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network

Epigenetic inactivation of the MIR129-2 in hematological malignancies

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

Molecular detection of minimal residual disease in multiple myeloma

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain

Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment

miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced‐intensity conditioning second transplantation from the original donor

Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients

Epigenetic inactivation of the miR-124-1 in haematological malignancies

DNA methylation of microRNA genes in multiple myeloma

Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma

Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma

Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR

Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma

Suchergebnisse filtern